Reduced symptoms and medication use after a 90-day follow-up
Together with optometry’s expertise in examining the physical appearance of the prelaminar optic nerve, the technology at our fingertips—namely spectral domain optical coherence tomography (OCT)—positions ODs to play a pivotal role in the
If an OD sees a lot of dry eye patients or has relatives with chronic pain, she may be familiar with how people feel pain differently. I am fortunate enough to be in both situations.
It is difficult to take it all in, let alone summarize the information gained by attending an Association of Research in Vision and Ophthalmology (ARVO) annual scientific meeting.
When ODs think about dry eye, they quickly associate classic demographics: Over-40 menopausal female patients taking a high number of medications or individuals with autoimmune disease.
A 55-year-old white male attended the clinic for evaluation with a vague chief complaint of reduced vision in each eye.
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or MultiMedia Healthcare.
I challenge everyone to ask your patients a few more questions during an exam. Specifically, screen for mental health concerns and make it part of optometry’s systemic disease investigation.
Myopia is expected to become a leading cause of permanent blindness around the world.1
Myopia is a disease—not a refractive error anymore, says Pamela Lowe, OD, FAAO, at Vision Expo East in New York City.
I enjoy good continuing education. Compelling lectures with high-resolution images keep me engaged, and I enjoy the act of silently quizzing myself to see if I can predict the correct diagnosis of an interesting case presentation.